Anlotinib HCl
Anlotinib is a receptor tyrosine kinase (RTK) inhibitor with potential anti-tumor and anti-angiogenic activities. When administered, anlotinib targets multiple RTKs, including VEGFR2 and VEGFR3, and the drug inhibits angiogenesis and prevents tumor cell growth.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0472 |
| Pricing | 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, inquire |